Abstract:Background Gene therapy applications require safe and efficient methods for gene transfer. Present methods are restricted by low efficiency and short duration of transgene expression. In vivo electroporation, a physical method of gene transfer, has evolved as an efficient method in recent years. We present a protocol involving electroporation combined with a long-acting promoter system for gene transfer to the lung.Methods The study was designed to evaluate electroporation-mediated gene transfer to the lung and to analyze a promoter system that allows prolonged transgene expression. A volume of 250 mu l of purified plasmid DNA suspended in water was instilled into the left lung of anesthetized rats, followed by left thoracotomy and electroporation of the exposed left lung. Plasmids pCiKlux and pUblux expressing luciferase under the control of the cytomegalovirus immediate-early promoter/enhancer (CMV-IEPE) or human polyubiquitin c (Ubc) promoter were used. Electroporation conditions were optimized with four pulses (200 V/cm, 20 ms at 1 Hz) using flat plate electrodes. The animals were sacrificed at different time points up to day 40, after gene transfer. Gene expression was detected and quantified by bioluminescent reporter imaging (BLI) and relative light units per milligram of protein (RLU/mg) was measured by luminometer for p.Pyralis luciferase and immunohistochemistry, using an anti-luciferase antibody.Results Gene expression with the CMV-IEPE promoter was highest 24 h after gene transfer (2932 +/- 249.4 relative light units (RLU)/mg of total lung protein) and returned to baseline by day 3 (382 +/- 318 RLU/mg of total lung protein); at day 5 no-expression was detected, whereas gene expression under the Ubc promoter was detected up to day 40 (1989 +/- 710 RLU/mg of total lung protein) with a peak at day 20 (2821 +/- 2092 RLU/mg of total lung protein). Arterial blood gas (PaO2), histological assessment and cytokine measurements showed no significant toxicity neither at day 1 nor at day 40.Conclusions These results provide evidence that in vivo electroporation is a safe and effective tool for non-viral gene delivery to the lungs. If this method is used in combination with a long-acting promoter system, sustained transgene expression can be achieved. Copyright (c) 2006 John Wiley & Sons, Ltd.

Prolonged Gene Expression in Mouse Lung Endothelial Cells Following Transfection with Epstein–Barr Virus-Based Episomal Plasmid

In Vivo Electroporation and Ubiquitin Promoter - A Protocol for Sustained Gene Expression in the Lung

Electroporation Enhances Reporter Gene Expression Following Delivery of Naked Plasmid Dna to the Lung

Endothelial targeting of the Sleeping Beauty transposon within lung

A Two‐Pronged Pulmonary Gene Delivery Strategy: A Surface‐Modified Fullerene Nanoparticle and a Hypotonic Vehicle

Prolonged siRNA expression in mammalian cells using an Epstein–Barr virus-based plasmid expression system

Efficiency of Non-Viral Gene Delivery Systems to Rat Lungs.

WS17.04 Developing a Non-Viral Gene Therapy Strategy for Treating Lung Cystic Fibrosis Disease

Highly Branched Poly Β-Amino Ester/cpg-Depleted CFTR Plasmid Nanoparticles for Non-viral Gene Therapy in Lung Cystic Fibrosis Disease

Breaching the Delivery Barrier: Chemical and Physical Airway Epithelium Disruption Strategies for Enhancing Lentiviral-Mediated Gene Therapy

PEGylated enhanced cell penetrating peptide nanoparticles for lung gene therapy

Gene expression in lung and liver after intravenous infusion of polyethylenimine complexes of Sleeping Beauty transposons

An OriP/EBNA-1-based baculovirus vector with prolonged and enhanced transgene expression.

Sustaining Expression of B Domain-Deleted Human Factor VIII Mediated by Using Lentiviral Vectors in NOD/SCID Mouse.

PBAE-PEG based lipid nanoparticles for lung cell-specific gene delivery

Sustained Expression of Epstein–Barr Virus Episomal Vector Mediated Factor VIII in Vivo Following Muscle Electroporation

An Improved Method for Increasing the Efficiency of Gene Transfection and Transduction.

Gene therapy for Cystic Fibrosis: Improved delivery techniques and conditioning with lysophosphatidylcholine enhance lentiviral gene transfer in mouse lung airways

Efficient and sustained gene expression in primary T lymphocytes and primary and cultured tumor cells mediated by adeno-associated virus plasmid DNA complexed to cationic liposomes

Suitability of Epstein-Barr virus-based episomal vectors for expression of cytokine genes in human lymphoma cells